Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Borel Fields's Profile
Displaying 201-250 of 343 result(s).
CYDY CytoDyn Inc
01/06/2021 11:29:50 PM
At the 50% interim, a 50% reduction (3)
CYDY CytoDyn Inc
01/06/2021 11:12:25 PM
Sure, I'll toss in my wild-ass gues (9)
CYDY CytoDyn Inc
01/06/2021 2:06:13 AM
Thanks so much. Another ten or twel (2)
CYDY CytoDyn Inc
01/05/2021 8:15:55 PM
Thanks, CTMedic, I missed that unti (6)
CYDY CytoDyn Inc
01/05/2021 6:03:09 PM
"Thinning, Leaky Brain Blood Vessel (1)
CYDY CytoDyn Inc
01/04/2021 3:50:06 PM
Does that sound like sequencing? GM (1)
CYDY CytoDyn Inc
01/04/2021 3:34:54 PM
You are correct that I was taking t
CYDY CytoDyn Inc
01/04/2021 2:20:06 PM
Help, please, re: leron/lenzi compa (1)
CYDY CytoDyn Inc
01/04/2021 10:50:30 AM
Leronlimab's supply from Samsung is (2)
CYDY CytoDyn Inc
01/04/2021 10:08:33 AM
Not a doc, but both now exclude the (2)
CYDY CytoDyn Inc
01/03/2021 6:26:45 PM
Rub - Given the number of platforms (2)
CYDY CytoDyn Inc
01/02/2021 9:27:14 PM
Anyone know details of NEWS2? I'm w (2)
CYDY CytoDyn Inc
01/02/2021 8:19:45 PM
Good arguments against using all-ca (3)
CYDY CytoDyn Inc
01/02/2021 1:28:54 AM
Another case saying EUAs take time: (3)
CYDY CytoDyn Inc
01/01/2021 2:44:57 AM
The good side of all cause mortalit (5)
CYDY CytoDyn Inc
12/29/2020 7:21:16 PM
Is the 1/21 effective date a typo o
CYDY CytoDyn Inc
12/26/2020 12:47:17 PM
CD-12 survivors are an ongoing long
CYDY CytoDyn Inc
12/26/2020 1:48:20 AM
Certainly, the FDA can see the deat
CYDY CytoDyn Inc
12/22/2020 1:58:49 AM
I worked for a while in a quantitat (3)
CYDY CytoDyn Inc
12/20/2020 2:11:56 AM
Clickbait is enough to track humans (2)
CYDY CytoDyn Inc
12/16/2020 2:23:57 PM
Samsung Mab capacity expanding - gr (6)
CYDY CytoDyn Inc
12/15/2020 11:30:36 AM
Use all the data: P(survive to 42) (6)
CYDY CytoDyn Inc
12/13/2020 7:08:24 PM
What happens at trial sites the day (1)
CYDY CytoDyn Inc
12/12/2020 10:34:46 PM
Was the "expanded access" tab on th (1)
CYDY CytoDyn Inc
12/12/2020 3:31:27 PM
Perfect. Thanks so much - I get the (1)
CYDY CytoDyn Inc
12/12/2020 11:09:49 AM
Thanks, Tech Guru, I used to think
CYDY CytoDyn Inc
12/10/2020 11:56:32 PM
If that's what they did, it is wron
CYDY CytoDyn Inc
11/25/2020 12:16:50 AM
No. I'm talking about post 66504
CYDY CytoDyn Inc
11/24/2020 11:03:32 PM
Exactly. The big thing is being cle
CYDY CytoDyn Inc
11/24/2020 5:33:38 PM
Simple product P(survive 42) = (# s (1)
CYDY CytoDyn Inc
11/24/2020 4:58:26 PM
The Cox model is the generalization (2)
CYDY CytoDyn Inc
11/16/2020 5:37:53 PM
Even 14-days post-293 enrollees, a (2)
CYDY CytoDyn Inc
11/13/2020 3:18:44 PM
Another view: Maraviroc, a small mo (5)
CYDY CytoDyn Inc
11/06/2020 9:46:16 PM
Repeating: information lies in even (5)
CYDY CytoDyn Inc
11/06/2020 9:42:21 PM
I hope I can help on the power fron (10)
CYDY CytoDyn Inc
10/29/2020 12:16:49 AM
Ohm - I've been trying to understan (4)
CYDY CytoDyn Inc
10/28/2020 6:14:15 PM
Only 6.5% of the placebo patients i (3)
CYDY CytoDyn Inc
10/28/2020 4:20:34 PM
Agree - it's clearly an "uneven pla (12)
CYDY CytoDyn Inc
10/26/2020 8:13:50 PM
Exactly. Information is measured in
CYDY CytoDyn Inc
10/21/2020 12:23:45 AM
So - the Meso GvHD CRL wasn't on hi (2)
CYDY CytoDyn Inc
10/21/2020 12:10:22 AM
Increasing mortality to 42 days is (4)
CYDY CytoDyn Inc
10/20/2020 10:06:17 PM
Rahman was just 13 months into runn
CYDY CytoDyn Inc
10/20/2020 12:39:58 PM
Let's not forget that OncoImmune pu
CYDY CytoDyn Inc
10/20/2020 10:22:09 AM
It's been a couple of hours - where (4)
CYDY CytoDyn Inc
10/18/2020 5:02:34 PM
Agree, sub-group analysis sucks - l
CYDY CytoDyn Inc
10/18/2020 11:50:42 AM
We will do a cohort (S alone, C alo (1)
CYDY CytoDyn Inc
10/16/2020 7:33:25 PM
Enrollment during interim analysis?
CYDY CytoDyn Inc
10/16/2020 7:24:08 PM
The 7-category ordinal scale: 1=dea (3)
CYDY CytoDyn Inc
10/16/2020 7:12:14 PM
Endpoint changes based solely on in (1)
CYDY CytoDyn Inc
10/16/2020 1:14:09 AM
By what process did OncoImmune deci
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • LifeMD, Inc.: Investors Encouraged to Claim Their Rights
  • Breaking News: Louvre Heist Culprits Arrested in France
  • Anthony Scaramucci Voices Support for Changpeng Zhao's Pardon
  • General Motors Ditches CarPlay: A Shift Towards Innovation
  • Exploring Trump's Bold Strategy of Gold for Bitcoin Exchange
  • Cristcot Showcases Promising UC Treatment Data at Annual Meeting
  • Innovative TissueCypher Test Enhances Management of Barrett's Esophagus
  • Seniors Express Concerns as Social Security Payments Increase
  • Castle Biosciences Unveils Key Data on TissueCypher at ACG
  • Cordis Announces Innovative Results from Groundbreaking Trials
  • Shaquille O'Neal's Luxury SUV Stolen in Cyber Heist
  • Marex Group plc Securities Class Action Update and Guidance
  • How the Fed's Balance Shift Could Impact Bitcoin Prices
  • ARETI International Group Sponsors Mayflower Gran Prix 2025
  • Big Week for Stocks: Major Gainers and Surprising Trends
  • Microsoft's Strategic Shift in AI Development and Ethics
  • U.S.-China Trade Agreement: Impact on Economy and Relations
  • Recent Trends in Large Cap Stocks: Key Market Movers
  • Avidity Biosciences Announces Acquisition by Novartis AG Deal
  • Legal Action Encouraged for Designer Brands Inc. Investors
  • Exploring the Future of Kratom: Insights from Kratom Bird
  • Novartis Enhances Neuroscience Pipeline Through Avidity Biosciences Acquisition
  • EggNest™ System: A Breakthrough in Radiation Safety for Cath Labs
  • Critical Importance of Court Reporting in High-Profile Trials
  • Mark Cuban's Insight: Billionaires and Market Stability
  • Blockchain Jungle 2025: Experience Innovation in Technology
  • Fortinet Shareholders Urged to Join Securities Class Action
  • Controversial $130 Million Donation to Pentagon Raises Concerns
  • Fate Therapeutics: Advances in CAR T-Cell Therapy for Lupus
  • JPMorgan Faces Legal Challenge Over Excessive Fraud Fees
  • JPMorgan Fights $115 Million Legal Fees After Fraud Case
  • Fate Therapeutics Unveils Promising Data on FT819 CAR T-Cell Therapy
  • Baxter International, Inc. Faces Class Action Lawsuit Amid Losses
  • ETC Mining Unveils Mobile App for Cloud Mining of XRP, BTC, ETH
  • Top 5 Stocks Gaining Investor Interest for Future Growth
  • Dow Inc. Class Action Lawsuit: Opportunities for Investors
  • WPP Investors Urged to Participate in Securities Class Action
  • Credit Blockchain Revolutionizes AI Integration in Crypto
  • Semler Investors Face Class Action Deadline - Act Now!
  • Urgent Alert for Dow Inc. Investors: Class Action Timeline Approaches
  • Trump's Bold Strategy: A Revolutionary Shift in Mining
  • LifeMD's Class Action Lawsuit: What Investors Need to Know
  • Tech Giants Face New Challenges Amid Rivalry and Innovation
  • America's Strategic Shift: Mining the Future of Resources
  • MSP Miner's Innovative Cloud Mining Platform for Universal Access
  • Celebrating Musical Excellence: Heida Hermanns Competition Event
  • Essential Steps for LifeMD Inc. Investors Before Deadline
  • Investors Encouraged to Review Claims Related to Savara Inc
  • Navigating Disagreements: Jeff Bezos' Unique Leadership Style
  • Investors Alert: Semler Scientific Faces Legal Investigation
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site